References
- Stojmenovic GM, Pavlovic AM, Gazibara MS, et al. Leptomeningeal carcinomatosis can be presenting manifestation of breast carcinoma. Vojnosanit Pregl. 2016;73:293–295.
- Fusco JP, Castanon E, Carranza OE, et al. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study. J Neurooncol. 2013;115:429–435.
- Aragon-Ching JB, Zujewski JA. CNS metastasis: an old problem in a new guise. Clin Cancer Res. 2007;13:1644–1647.
- Martins S, Zevedo AC, Chinen L, et al. Meningeal carcinomatosis in solid tumors. Arq Neuro-Psiquiat. 2011;69:973–980.
- Chamberlain M. Combined-modality treatment of leptomeningeal gliomatosis. Neurosurgery. 2003;52:330.
- Guan Q, Zhang L, Ji L, et al. The clinical features of meningeal carcinomatosis. J Clin Neurol. 2012;25:461–462.
- Kim L, Glantz M. Neoplastic meningitis. Lancet Neurol. 2006;5:443–452.
- Van Horn A, Chamberlain M. Neoplastic meningitis. J Support Oncol. 2012;10:45–53.
- Chamberlain MC, Glantz M, Groves MD, et al. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36:S35–S45.
- Straathof C, Bruin H, Dippel D, et al. Thediagnostic accuracy of magnetic resonance imagingand cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol. 1999;246:810–814.
- Kak M, Nanda R, Ramsdale EE, et al. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities. J Clin Neurosci. 2015;22:632–637.
- Jung TY, Chung WK, Oh IJ. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases. Clin Neurol Neurosurg. 2014;119:80–83.
- Herrlinger U, Wiendl H, Renninger M, et al. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. Br J Cancer. 2004;91:219–224.
- Reijneveld JC, Brandsma D, Boogerd W, et al. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases. Neurology. 2005;65:1120–1122.
- Palma JA, Fernandez-Torron R, Esteve-Belloch P, et al. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features. Clin Neurol Neurosurg. 2013;115:19–25.
- Oechsle K, Lange-Brock V, Kruell A, et al. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol. 2010;136:1729–1735.
- Xu Q, Chen X, Qian D, et al. Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer. Thorac Cancer. 2015;6:407–412.